Pipeline companies are accustomed to navigating the thicket of regulatory requirements, but now they’re also learning how to win the war of public relations.
This blue chip pharmaceutical firm has taken it on the chin lately, but several new drugs in the pipeline should hold it in good stead.
CEO Marissa Mayer’s latest acquisition is her biggest yet. Here are some of the opportunities—and risks—it presents for the company.
Investment in wireless and wireline network technology continues to rise all over the world–except in Europe. This trend might be about to change.
Booming US crude supply should dramatically reduce the power of the oil exporters’ cartel, despite the market’s current skepticism.
An innovative entity designed to spark entrepreneurialism and business development also makes a good investment play.
This “Obamacare play” is poised to benefit from the government’s expansion of the health care arena.
With a lock on lucrative and growing travel markets, Alaska Air Group is flying higher than its peers.
Hedge fund manager Dan Loeb’s billion-dollar new stake could pay off big even if the company spurns him.
Forget the hype, half-truths, spin, and political ax-grinding: Here’s what the US budget deficit really means for the markets.